Csenge Advisory Group
- SEC CIK
- 0001715593
- Latest filing
- Aug 10, 2026
LRCX holding history
Lam Research Corp in every 13F filed by Csenge Advisory Group, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LRCX overviewAll 13F holders of LRCXFull Q2 2026 holdings
- Shares (Q2 2026)
- 2,062
- Value
- $893.3K
- % of portfolio
- <0.1%
- Quarters held
- 14
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 2,062 | $893.3K | <0.1% | +90+4.6% | Added | Holders |
| Q1 2026 | 1,972 | $421.3K | <0.1% | +132+7.2% | Added | Holders |
| Q4 2025 | 1,840 | $315.0K | <0.1% | +243+15.2% | Added | Holders |
| Q3 2025 | 1,597 | $213.9K | <0.1% | +1,597 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −28,110−100.0% | Sold outConverted for a 10-for-1 split | Holders |
| Q3 2024 | 2,811 | $233.0K | <0.1% | +2,500+803.9% | Added | Holders |
| Q2 2024 | 311 | $331.2K | <0.1% | +5+1.6% | Added | Holders |
| Q1 2024 | 306 | $297.3K | <0.1% | +21+7.4% | Added | Holders |
| Q4 2023 | 285 | $223.2K | <0.1% | +285 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −313−100.0% | Sold out | Holders |
| Q2 2023 | 313 | $201.2K | <0.1% | +313 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −430−100.0% | Sold out | Holders |
| Q1 2022 | 430 | $231.0K | <0.1% | −71−14.2% | Reduced | Holders |
| Q4 2021 | 501 | $317.0K | <0.1% | −18−3.5% | Reduced | Holders |
| Q3 2021 | 519 | $296.0K | <0.1% | +18+3.6% | Added | Holders |
| Q2 2021 | 501 | $317.0K | <0.1% | −488−49.3% | Reduced | Holders |
| Q1 2021 | 989 | $655.0K | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.